U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2024
711
Name Type Language
Nogapendekin Alfa Inbakicept
Common Name English
Nogapendekin Alfa Inbakicept-PMLN
FDA  
Preferred Name English
N-803
Code English
INBAKICEPT NOGAPENDEKIN ALFA FUSION COMPLEX
Common Name English
IL-15N72D:IL-15REC-SU/FC SOLUBLE COMPLEX I
Common Name English
Nogapendekin alfa inbakicept [WHO-DD]
Common Name English
ALT-803
Code English
fusion protein consisting of IL-15N72D and IL-15RaSu/Fc
Common Name English
ANKTIVA
Brand Name English
SUPERAGONIST INTERLEUKIN-15:INTERLEUKIN-15 RECEPTOR ALPHASU/FC FUSION COMPLEX ALT-803
Common Name English
Code System Code Type Description
NCI_THESAURUS
C205507
Created by admin on Mon Mar 31 23:40:23 GMT 2025 , Edited by admin on Mon Mar 31 23:40:23 GMT 2025
PRIMARY
DAILYMED
7TK323DLA0
Created by admin on Mon Mar 31 23:40:23 GMT 2025 , Edited by admin on Mon Mar 31 23:40:23 GMT 2025
PRIMARY
CAS
1850381-92-8
Created by admin on Mon Mar 31 23:40:23 GMT 2025 , Edited by admin on Mon Mar 31 23:40:23 GMT 2025
NO STRUCTURE GIVEN
SMS_ID
100000181907
Created by admin on Mon Mar 31 23:40:23 GMT 2025 , Edited by admin on Mon Mar 31 23:40:23 GMT 2025
PRIMARY
FDA UNII
7TK323DLA0
Created by admin on Mon Mar 31 23:40:23 GMT 2025 , Edited by admin on Mon Mar 31 23:40:23 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966